Adoptive transfer of virus-specific and tumor-specific T cell immunity
- 21 March 2009
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 21 (2) , 224-232
- https://doi.org/10.1016/j.coi.2009.02.010
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanomaProceedings of the National Academy of Sciences, 2007
- The Genomic Landscapes of Human Breast and Colorectal CancersScience, 2007
- Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapyNature Reviews Cancer, 2007
- Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferBlood, 2007
- Adoptive immunotherapy for cancer: building on successNature Reviews Immunology, 2006
- Infusion of cytomegalovirus (CMV)–specific T cells for the treatment of CMV infection not responding to antiviral chemotherapyBlood, 2002
- Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transferNature Immunology, 2001
- Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assayNature Medicine, 2001
- Adoptive Transfer of Cloned Melanoma-Reactive T Lymphocytes for the Treatment of Patients with Metastatic MelanomaJournal of Immunotherapy, 2001
- Glucocorticoids in T Cell Development and FunctionAnnual Review of Immunology, 2000